Emergency icon Important Updates

Katherine Dell, MD

Katherine Dell, MD
  • No ratings
  • 0 Patient Satisfaction Ratings
  • 0 Patient Comments
Title Staff, Pediatric Nephrology & Vice Chair of Research, Pediatric Institute
Department Center for Pediatric Nephrology and Hypertension
Primary Location Cleveland Clinic Main Campus
Type of Doctor Children & Adolescents Only
Languages English
Surgeon No
Locations Specialties & Treatments

Treatment & Services

  • Center for Pediatric Nephrology
View all 1 Treatment & Services +

Specialty in Diseases & Conditions

  • Blood in the Urine
  • Chronic Kidney Disease
  • Fetal Kidney Disease
  • Focal Segmental Glomerulosclerosis (FSGS)
  • High Creatinine Levels
  • Inherited Kidney Disease
  • Lupus Nephritis
  • Metabolic Acidosis
  • Nephrotic Syndrome
  • Pediatric Kidney Birth Defects
  • Polycystic Kidney Disease
View all 11 Specialties +
Insurance

Insurance

Is Cleveland Clinic Part of Your Insurance?

Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.

View All Plans
Biography

About Katherine Dell, MD

Katherine M. Dell, M.D. is a board-certified Pediatric nephrologist and Vice Chair of Research for the Pediatric Institute.  She sees patients at Cleveland Clinic Children's outpatient facility on Main campus as well as at Richard E Jacobs Health Center and Hillcrest Hospital outpatient facilities.

She received her medical degree from Harvard Medical School and completed pediatric residency and pediatric nephrology fellowship at Children's Hospital of Philadelphia.  

She is a member of several professional organizations including the American Society of Pediatric Nephrology, American Academy of Pediatrics and the Society for Pediatric Research.

She has published over 50 articles in peer-reviewed journals. She is the site principle investigator for several clinical research studies and networks including Chronic Kidney Disease in Children (CKID),  Nephrotic Syndrome Study Network (NEPTUNE) and North American Pediatric Renal Trials Cooperative Study (NAPRTCs).  She also participates in several treatment studies in nephrotic syndrome.

Her specialty interests include polycystic kidney disease (PKD) and other cystic kidney diseases (including tuberous sclerosis), obstructive uropathies (including posterior urethral valves), nephrotic syndrome and pediatric chronic kidney disease (CKD).

Her research focuses on development and application of quantitative magnetic resonance imaging (MRI) techniques as biomarkers for chronic kidney disease progression, including progression of autosomal recessive polycystic kidney disease (ARPKD).

Education & Professional Highlights

Education & Professional Highlights

Appointed
2013

Education & Fellowships

Fellowship - Children's Hospital of Philadelphia
Pediatric Nephrology
Philadelphia, PA
1998

Residency - Children's Hospital of Philadelphia
Pediatrics
Philadelphia, PA
1995

Medical Education - Harvard University Medical School
Boston, MA
1992

Undergraduate - Yale University
New Haven, CT
1987

Certifications

  • Pediatrics
  • Pediatrics - Pediatric Nephrology

Specialty Interests

Inherited kidney diseases, polycystic kidney disease, congenital kidney malformations

Research & Publications

Research & Publications

See publications for Katherine Dell, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 1/8/2024, Dr. Dell has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Back to Top